|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-1-30
|
|
pubmed:abstractText |
Benign prostatic hyperplasia (BPH) was shown to be associated with high concentrations of urinary prostate specific antigen (PSA). We investigated the serum-to-urinary PSA ratio in patients undergoing prostate biopsy to assess its efficacy in enhancing serum PSA specificity in the detection of prostate carcinoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
157
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
185-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8976247-Aged,
pubmed-meshheading:8976247-Aged, 80 and over,
pubmed-meshheading:8976247-Diagnosis, Differential,
pubmed-meshheading:8976247-Humans,
pubmed-meshheading:8976247-Male,
pubmed-meshheading:8976247-Middle Aged,
pubmed-meshheading:8976247-Prospective Studies,
pubmed-meshheading:8976247-Prostate-Specific Antigen,
pubmed-meshheading:8976247-Prostatic Neoplasms,
pubmed-meshheading:8976247-Sensitivity and Specificity
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./ml.
|
|
pubmed:affiliation |
Departments of Urology, Nuclear Medicine and Pathology, Centre Hospitalier Universitaire, La Milétrie, Poitiers, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
